Katja Gist
Concepts (316)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 106 | 2026 | 866 | 23.180 |
Why?
| | Cardiac Surgical Procedures | 28 | 2025 | 611 | 7.510 |
Why?
| | Renal Replacement Therapy | 22 | 2026 | 102 | 5.030 |
Why?
| | Water-Electrolyte Imbalance | 15 | 2026 | 39 | 4.540 |
Why?
| | Extracorporeal Membrane Oxygenation | 10 | 2026 | 370 | 4.110 |
Why?
| | Creatinine | 19 | 2025 | 511 | 3.480 |
Why?
| | Critical Illness | 28 | 2026 | 908 | 3.390 |
Why?
| | Postoperative Complications | 25 | 2026 | 3034 | 3.250 |
Why?
| | Lipocalin-2 | 7 | 2025 | 80 | 3.000 |
Why?
| | Heart Defects, Congenital | 12 | 2026 | 923 | 2.390 |
Why?
| | Infant, Newborn | 62 | 2026 | 6460 | 2.320 |
Why?
| | Water-Electrolyte Balance | 10 | 2026 | 37 | 2.250 |
Why?
| | Milrinone | 5 | 2021 | 26 | 2.240 |
Why?
| | Child | 83 | 2026 | 22693 | 2.070 |
Why?
| | Biomarkers | 21 | 2025 | 4340 | 1.960 |
Why?
| | Cardiopulmonary Bypass | 7 | 2024 | 217 | 1.870 |
Why?
| | Kidney | 16 | 2025 | 1498 | 1.830 |
Why?
| | Infant | 53 | 2026 | 10114 | 1.820 |
Why?
| | Norwood Procedures | 4 | 2024 | 33 | 1.770 |
Why?
| | Retrospective Studies | 74 | 2026 | 17438 | 1.700 |
Why?
| | Peritoneal Dialysis | 3 | 2020 | 100 | 1.640 |
Why?
| | Chlorides | 3 | 2020 | 138 | 1.600 |
Why?
| | Child, Preschool | 46 | 2026 | 11913 | 1.560 |
Why?
| | Risk Factors | 38 | 2026 | 10921 | 1.420 |
Why?
| | Furosemide | 4 | 2025 | 37 | 1.410 |
Why?
| | Humans | 142 | 2026 | 146342 | 1.360 |
Why?
| | Hypertension | 3 | 2026 | 1272 | 1.310 |
Why?
| | Arterial Switch Operation | 2 | 2020 | 16 | 1.270 |
Why?
| | Prospective Studies | 24 | 2025 | 8123 | 1.260 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2018 | 119 | 1.230 |
Why?
| | Male | 84 | 2026 | 73396 | 1.200 |
Why?
| | Intensive Care Units, Pediatric | 14 | 2026 | 293 | 1.160 |
Why?
| | Female | 81 | 2026 | 79499 | 1.100 |
Why?
| | Heart Diseases | 3 | 2025 | 343 | 1.060 |
Why?
| | Multiple Organ Failure | 2 | 2025 | 122 | 1.050 |
Why?
| | Length of Stay | 16 | 2026 | 1358 | 1.040 |
Why?
| | Sepsis | 4 | 2025 | 669 | 1.000 |
Why?
| | Hospital Mortality | 13 | 2024 | 1051 | 1.000 |
Why?
| | Anticoagulants | 4 | 2025 | 746 | 0.930 |
Why?
| | Hypoxia-Ischemia, Brain | 2 | 2024 | 50 | 0.930 |
Why?
| | Adolescent | 40 | 2026 | 22557 | 0.930 |
Why?
| | Acute Lung Injury | 2 | 2026 | 312 | 0.900 |
Why?
| | Citric Acid | 1 | 2025 | 33 | 0.900 |
Why?
| | Renal Insufficiency, Chronic | 4 | 2026 | 640 | 0.870 |
Why?
| | Chemokines, CC | 1 | 2024 | 33 | 0.850 |
Why?
| | Heart Failure | 5 | 2023 | 2329 | 0.850 |
Why?
| | Sodium Potassium Chloride Symporter Inhibitors | 1 | 2024 | 17 | 0.840 |
Why?
| | Shock, Cardiogenic | 1 | 2024 | 65 | 0.820 |
Why?
| | Infant, Premature, Diseases | 1 | 2025 | 113 | 0.820 |
Why?
| | Respiration, Artificial | 13 | 2026 | 711 | 0.800 |
Why?
| | Registries | 13 | 2026 | 2400 | 0.750 |
Why?
| | Reperfusion Injury | 2 | 2022 | 300 | 0.740 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 3 | 2021 | 14 | 0.690 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 3 | 2021 | 26 | 0.680 |
Why?
| | Critical Care | 6 | 2024 | 706 | 0.680 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2022 | 334 | 0.670 |
Why?
| | Cardio-Renal Syndrome | 2 | 2019 | 20 | 0.670 |
Why?
| | Phenotype | 3 | 2024 | 3206 | 0.660 |
Why?
| | Cystatin C | 2 | 2021 | 65 | 0.620 |
Why?
| | Treatment Outcome | 22 | 2026 | 11821 | 0.620 |
Why?
| | Young Adult | 26 | 2026 | 14330 | 0.610 |
Why?
| | Diuretics | 4 | 2025 | 66 | 0.610 |
Why?
| | Glomerular Filtration Rate | 3 | 2022 | 745 | 0.600 |
Why?
| | Erythropoietin | 3 | 2025 | 100 | 0.560 |
Why?
| | Fontan Procedure | 2 | 2019 | 200 | 0.560 |
Why?
| | Aorta, Thoracic | 1 | 2021 | 284 | 0.560 |
Why?
| | Fluid Therapy | 1 | 2020 | 154 | 0.560 |
Why?
| | Esthetics | 1 | 2018 | 49 | 0.560 |
Why?
| | Cicatrix | 1 | 2018 | 72 | 0.540 |
Why?
| | Publications | 1 | 2018 | 48 | 0.530 |
Why?
| | Intensive Care Units | 9 | 2024 | 925 | 0.510 |
Why?
| | Pacemaker, Artificial | 1 | 2018 | 127 | 0.510 |
Why?
| | Vasodilator Agents | 2 | 2016 | 326 | 0.500 |
Why?
| | Renal Insufficiency | 1 | 2019 | 173 | 0.490 |
Why?
| | Jugular Veins | 2 | 2019 | 41 | 0.490 |
Why?
| | Postoperative Care | 1 | 2018 | 301 | 0.480 |
Why?
| | Reoperation | 1 | 2019 | 645 | 0.470 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2016 | 70 | 0.460 |
Why?
| | Cohort Studies | 11 | 2025 | 6077 | 0.450 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 393 | 0.420 |
Why?
| | Brain | 3 | 2024 | 2991 | 0.410 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2014 | 37 | 0.410 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1221 | 0.390 |
Why?
| | Heart Transplantation | 3 | 2026 | 682 | 0.380 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 3 | 2024 | 42 | 0.380 |
Why?
| | Consensus | 3 | 2024 | 467 | 0.370 |
Why?
| | Lung | 2 | 2025 | 4122 | 0.370 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2013 | 27 | 0.370 |
Why?
| | Heparin | 1 | 2014 | 247 | 0.370 |
Why?
| | Neonatologists | 2 | 2026 | 12 | 0.360 |
Why?
| | Nephrologists | 2 | 2026 | 13 | 0.360 |
Why?
| | Lipocalins | 2 | 2024 | 35 | 0.360 |
Why?
| | Renal Dialysis | 4 | 2024 | 461 | 0.360 |
Why?
| | Risk Assessment | 8 | 2025 | 3712 | 0.350 |
Why?
| | Venous Thrombosis | 1 | 2014 | 199 | 0.350 |
Why?
| | Hypothermia, Induced | 2 | 2024 | 96 | 0.340 |
Why?
| | Quality Improvement | 4 | 2026 | 1354 | 0.340 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2012 | 49 | 0.330 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3926 | 0.330 |
Why?
| | Systemic Inflammatory Response Syndrome | 5 | 2022 | 97 | 0.330 |
Why?
| | Body Surface Potential Mapping | 1 | 2010 | 8 | 0.330 |
Why?
| | Severity of Illness Index | 7 | 2026 | 2921 | 0.330 |
Why?
| | Aspirin | 1 | 2014 | 405 | 0.320 |
Why?
| | Thrombocytopenia | 2 | 2025 | 206 | 0.320 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 1 | 2010 | 28 | 0.320 |
Why?
| | Quality of Life | 2 | 2023 | 3200 | 0.320 |
Why?
| | Predictive Value of Tests | 3 | 2025 | 2113 | 0.310 |
Why?
| | Time Factors | 10 | 2026 | 7109 | 0.310 |
Why?
| | Incidence | 4 | 2022 | 2936 | 0.310 |
Why?
| | Intensive Care Units, Neonatal | 5 | 2024 | 295 | 0.300 |
Why?
| | Gestational Age | 6 | 2025 | 990 | 0.300 |
Why?
| | Cryosurgery | 1 | 2009 | 46 | 0.290 |
Why?
| | Tachycardia, Supraventricular | 1 | 2009 | 50 | 0.290 |
Why?
| | Models, Biological | 2 | 2019 | 1761 | 0.290 |
Why?
| | Heart Conduction System | 1 | 2009 | 96 | 0.290 |
Why?
| | Cardiotonic Agents | 2 | 2021 | 96 | 0.290 |
Why?
| | Prognosis | 6 | 2025 | 4351 | 0.280 |
Why?
| | Heart | 3 | 2022 | 626 | 0.270 |
Why?
| | Delphi Technique | 3 | 2024 | 350 | 0.260 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2023 | 427 | 0.260 |
Why?
| | Ischemia | 2 | 2022 | 421 | 0.260 |
Why?
| | Child, Hospitalized | 3 | 2022 | 52 | 0.250 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1116 | 0.250 |
Why?
| | Catheter Ablation | 1 | 2010 | 355 | 0.240 |
Why?
| | Survival Rate | 4 | 2024 | 2092 | 0.240 |
Why?
| | Age Factors | 6 | 2022 | 3347 | 0.240 |
Why?
| | Vasoconstrictor Agents | 2 | 2024 | 148 | 0.240 |
Why?
| | Nephrology | 2 | 2026 | 59 | 0.230 |
Why?
| | Logistic Models | 5 | 2024 | 2126 | 0.230 |
Why?
| | Supervised Machine Learning | 1 | 2025 | 23 | 0.230 |
Why?
| | Interleukin-18 | 2 | 2024 | 234 | 0.220 |
Why?
| | Postoperative Period | 3 | 2024 | 355 | 0.220 |
Why?
| | Nomograms | 1 | 2025 | 59 | 0.220 |
Why?
| | Infant, Extremely Premature | 1 | 2025 | 67 | 0.220 |
Why?
| | Surveys and Questionnaires | 7 | 2026 | 6073 | 0.210 |
Why?
| | Bumetanide | 1 | 2024 | 6 | 0.210 |
Why?
| | Adult | 15 | 2026 | 41087 | 0.210 |
Why?
| | Renin | 1 | 2024 | 33 | 0.210 |
Why?
| | Addison Disease | 1 | 2024 | 38 | 0.210 |
Why?
| | Comorbidity | 5 | 2022 | 1665 | 0.210 |
Why?
| | Adrenal Insufficiency | 1 | 2024 | 31 | 0.210 |
Why?
| | Bone Marrow Transplantation | 1 | 2025 | 301 | 0.210 |
Why?
| | Vasopressins | 1 | 2024 | 60 | 0.210 |
Why?
| | Acute Disease | 5 | 2023 | 1038 | 0.200 |
Why?
| | Consent Forms | 1 | 2023 | 12 | 0.200 |
Why?
| | Cardiac Output, Low | 2 | 2021 | 53 | 0.200 |
Why?
| | Global Health | 2 | 2024 | 403 | 0.200 |
Why?
| | Infant, Premature | 4 | 2024 | 622 | 0.190 |
Why?
| | Practice Patterns, Physicians' | 2 | 2026 | 1408 | 0.190 |
Why?
| | Health Information Systems | 1 | 2022 | 16 | 0.190 |
Why?
| | Odds Ratio | 3 | 2022 | 1077 | 0.180 |
Why?
| | Hydrocortisone | 1 | 2024 | 303 | 0.180 |
Why?
| | Hydroxamic Acids | 1 | 2022 | 96 | 0.180 |
Why?
| | Forecasting | 1 | 2024 | 388 | 0.180 |
Why?
| | Machine Learning | 2 | 2025 | 594 | 0.180 |
Why?
| | Informed Consent | 1 | 2023 | 195 | 0.180 |
Why?
| | Hypernatremia | 1 | 2021 | 7 | 0.180 |
Why?
| | Proportional Hazards Models | 1 | 2025 | 1331 | 0.170 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 113 | 0.170 |
Why?
| | Sodium | 1 | 2022 | 196 | 0.170 |
Why?
| | Antihypertensive Agents | 1 | 2026 | 519 | 0.170 |
Why?
| | Blood Pressure | 2 | 2026 | 1765 | 0.170 |
Why?
| | Hyponatremia | 1 | 2021 | 42 | 0.170 |
Why?
| | ROC Curve | 4 | 2025 | 617 | 0.170 |
Why?
| | Benzodiazepines | 1 | 2022 | 158 | 0.170 |
Why?
| | Hyperglycemia | 1 | 2025 | 384 | 0.170 |
Why?
| | Mice, Inbred C57BL | 2 | 2022 | 6034 | 0.160 |
Why?
| | Survival Analysis | 3 | 2020 | 1378 | 0.160 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2022 | 219 | 0.160 |
Why?
| | Coinfection | 1 | 2022 | 143 | 0.160 |
Why?
| | Multivariate Analysis | 1 | 2024 | 1543 | 0.160 |
Why?
| | Catheters, Indwelling | 1 | 2020 | 94 | 0.160 |
Why?
| | Child Development | 1 | 2025 | 481 | 0.150 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 87 | 0.150 |
Why?
| | Bicarbonates | 1 | 2020 | 44 | 0.150 |
Why?
| | Perfusion | 1 | 2021 | 255 | 0.150 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 266 | 0.150 |
Why?
| | Metabolic Clearance Rate | 2 | 2019 | 115 | 0.150 |
Why?
| | Aminoglycosides | 3 | 2025 | 29 | 0.150 |
Why?
| | Kidney Failure, Chronic | 1 | 2025 | 589 | 0.150 |
Why?
| | Phosphodiesterase 3 Inhibitors | 1 | 2019 | 14 | 0.150 |
Why?
| | Bioprosthesis | 1 | 2019 | 39 | 0.140 |
Why?
| | Heart Failure, Diastolic | 1 | 2019 | 23 | 0.140 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2021 | 188 | 0.140 |
Why?
| | Kinetics | 2 | 2024 | 1553 | 0.140 |
Why?
| | Prevalence | 1 | 2026 | 2861 | 0.140 |
Why?
| | Asphyxia Neonatorum | 1 | 2018 | 20 | 0.140 |
Why?
| | Kidney Function Tests | 1 | 2019 | 156 | 0.140 |
Why?
| | Guideline Adherence | 1 | 2023 | 594 | 0.140 |
Why?
| | United States | 8 | 2025 | 16136 | 0.130 |
Why?
| | Recurrence | 2 | 2019 | 1133 | 0.130 |
Why?
| | Echocardiography | 3 | 2019 | 645 | 0.130 |
Why?
| | Heart Valve Diseases | 1 | 2019 | 151 | 0.130 |
Why?
| | Inpatients | 1 | 2022 | 540 | 0.130 |
Why?
| | Heart Valve Prosthesis | 1 | 2019 | 127 | 0.130 |
Why?
| | Anti-Bacterial Agents | 2 | 2025 | 1942 | 0.130 |
Why?
| | Early Medical Intervention | 1 | 2018 | 59 | 0.130 |
Why?
| | Pulmonary Valve | 1 | 2019 | 100 | 0.130 |
Why?
| | Chi-Square Distribution | 2 | 2021 | 517 | 0.130 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 187 | 0.130 |
Why?
| | Propensity Score | 1 | 2019 | 376 | 0.130 |
Why?
| | Brain Diseases | 1 | 2018 | 159 | 0.120 |
Why?
| | Follow-Up Studies | 4 | 2025 | 5439 | 0.120 |
Why?
| | Pain | 1 | 2022 | 790 | 0.120 |
Why?
| | Early Diagnosis | 1 | 2018 | 251 | 0.120 |
Why?
| | Cell Cycle Checkpoints | 1 | 2017 | 97 | 0.120 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2019 | 197 | 0.120 |
Why?
| | Immunocompromised Host | 1 | 2018 | 201 | 0.120 |
Why?
| | Research Design | 1 | 2022 | 1143 | 0.120 |
Why?
| | Thoracic Surgery | 1 | 2018 | 145 | 0.120 |
Why?
| | Pilot Projects | 2 | 2021 | 1888 | 0.120 |
Why?
| | Hemodynamics | 1 | 2021 | 1114 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 2022 | 0.110 |
Why?
| | Hospitalization | 3 | 2021 | 2475 | 0.110 |
Why?
| | Algorithms | 1 | 2022 | 1849 | 0.110 |
Why?
| | Cattle | 2 | 2019 | 940 | 0.100 |
Why?
| | Hospitals, Pediatric | 3 | 2025 | 561 | 0.100 |
Why?
| | Tachycardia | 1 | 2014 | 58 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2021 | 635 | 0.100 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 5899 | 0.100 |
Why?
| | Bayes Theorem | 1 | 2015 | 426 | 0.100 |
Why?
| | Vancomycin | 2 | 2025 | 96 | 0.100 |
Why?
| | Birth Weight | 3 | 2023 | 521 | 0.100 |
Why?
| | Blalock-Taussig Procedure | 1 | 2013 | 6 | 0.100 |
Why?
| | Fetal Growth Retardation | 1 | 2018 | 592 | 0.090 |
Why?
| | Feasibility Studies | 1 | 2017 | 1135 | 0.090 |
Why?
| | Catheterization | 1 | 2013 | 179 | 0.090 |
Why?
| | Mice | 4 | 2022 | 18297 | 0.090 |
Why?
| | Oxidative Stress | 1 | 2019 | 1369 | 0.090 |
Why?
| | Animals | 6 | 2022 | 38107 | 0.090 |
Why?
| | Ventricular Function, Right | 1 | 2014 | 300 | 0.080 |
Why?
| | Coronary Angiography | 1 | 2013 | 325 | 0.080 |
Why?
| | Organ Size | 1 | 2012 | 465 | 0.080 |
Why?
| | Colorado | 2 | 2018 | 4595 | 0.080 |
Why?
| | Fluoroscopy | 1 | 2010 | 179 | 0.080 |
Why?
| | Pulmonary Embolism | 1 | 2012 | 246 | 0.080 |
Why?
| | Professional Competence | 1 | 2010 | 90 | 0.080 |
Why?
| | Age Distribution | 2 | 2022 | 399 | 0.080 |
Why?
| | Acute-Phase Proteins | 2 | 2019 | 66 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1408 | 0.070 |
Why?
| | Body Weight | 2 | 2025 | 968 | 0.070 |
Why?
| | Aging | 1 | 2019 | 1996 | 0.070 |
Why?
| | Aged | 3 | 2022 | 26432 | 0.060 |
Why?
| | India | 2 | 2018 | 213 | 0.060 |
Why?
| | Canada | 2 | 2019 | 432 | 0.060 |
Why?
| | Neoplasms | 1 | 2022 | 2954 | 0.060 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2026 | 66 | 0.060 |
Why?
| | Diastole | 1 | 2026 | 147 | 0.060 |
Why?
| | Platelet Count | 1 | 2025 | 95 | 0.050 |
Why?
| | Databases, Factual | 2 | 2022 | 1493 | 0.050 |
Why?
| | Body Height | 1 | 2025 | 205 | 0.050 |
Why?
| | Organ Dysfunction Scores | 1 | 2024 | 55 | 0.050 |
Why?
| | Neuroprotection | 1 | 2023 | 46 | 0.050 |
Why?
| | Parenteral Nutrition, Total | 1 | 2022 | 27 | 0.050 |
Why?
| | Cardiac Catheterization | 1 | 2026 | 571 | 0.050 |
Why?
| | Potassium | 1 | 2022 | 151 | 0.040 |
Why?
| | Prostaglandins | 1 | 2021 | 94 | 0.040 |
Why?
| | Educational Status | 1 | 2023 | 466 | 0.040 |
Why?
| | Confidence Intervals | 1 | 2022 | 329 | 0.040 |
Why?
| | Michigan | 1 | 2021 | 203 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2023 | 267 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 2219 | 0.040 |
Why?
| | Societies, Medical | 1 | 2024 | 907 | 0.040 |
Why?
| | Graft Survival | 1 | 2022 | 523 | 0.040 |
Why?
| | Fluid Shifts | 1 | 2019 | 2 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2022 | 4580 | 0.040 |
Why?
| | Matched-Pair Analysis | 1 | 2019 | 38 | 0.040 |
Why?
| | Goals | 1 | 2021 | 187 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2019 | 151 | 0.040 |
Why?
| | Sex Distribution | 1 | 2019 | 382 | 0.040 |
Why?
| | Term Birth | 1 | 2018 | 25 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 196 | 0.030 |
Why?
| | Urodynamics | 1 | 2019 | 44 | 0.030 |
Why?
| | Hepatocytes | 1 | 2019 | 224 | 0.030 |
Why?
| | Datasets as Topic | 1 | 2018 | 120 | 0.030 |
Why?
| | Substance Abuse, Intravenous | 1 | 2019 | 131 | 0.030 |
Why?
| | Homeostasis | 1 | 2022 | 646 | 0.030 |
Why?
| | Dialysis | 1 | 2017 | 18 | 0.030 |
Why?
| | North America | 1 | 2018 | 300 | 0.030 |
Why?
| | History, 20th Century | 1 | 2019 | 330 | 0.030 |
Why?
| | New Zealand | 1 | 2017 | 56 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2026 | 1219 | 0.030 |
Why?
| | RNA, Viral | 1 | 2021 | 693 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2019 | 358 | 0.030 |
Why?
| | Pregnancy | 2 | 2021 | 7230 | 0.030 |
Why?
| | Australia | 1 | 2017 | 291 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 2107 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2019 | 784 | 0.030 |
Why?
| | Metabolome | 1 | 2019 | 390 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2360 | 0.030 |
Why?
| | Weight Gain | 1 | 2018 | 562 | 0.030 |
Why?
| | Premature Birth | 1 | 2018 | 390 | 0.030 |
Why?
| | Middle Aged | 3 | 2022 | 36619 | 0.020 |
Why?
| | Myocardium | 1 | 2019 | 948 | 0.020 |
Why?
| | Metabolomics | 1 | 2019 | 738 | 0.020 |
Why?
| | Body Mass Index | 1 | 2022 | 2458 | 0.020 |
Why?
| | Patient Discharge | 1 | 2020 | 997 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2019 | 930 | 0.020 |
Why?
| | Smoking | 1 | 2019 | 1486 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 1993 | 105 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 1993 | 154 | 0.020 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 1993 | 104 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3647 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 1101 | 0.020 |
Why?
| | Stroke | 1 | 2019 | 1287 | 0.020 |
Why?
| | Diagnostic Imaging | 1 | 2012 | 340 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2022 | 8391 | 0.020 |
Why?
| | Electrocardiography | 1 | 2012 | 667 | 0.020 |
Why?
| | Fetal Organ Maturity | 1 | 1993 | 13 | 0.010 |
Why?
| | Placebos | 1 | 1993 | 192 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1993 | 125 | 0.010 |
Why?
| | Retinopathy of Prematurity | 1 | 1993 | 183 | 0.000 |
Why?
| | Cerebral Palsy | 1 | 1993 | 149 | 0.000 |
Why?
| | Psychomotor Performance | 1 | 1993 | 329 | 0.000 |
Why?
| | Intubation, Intratracheal | 1 | 1993 | 330 | 0.000 |
Why?
| | Lung Diseases | 1 | 1993 | 787 | 0.000 |
Why?
|
|
Gist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|